Innocoll Holdings plc to Present at the Piper Jaffray Annual Healthcare Conference
23 nov. 2016 08h00 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, Nov. 23, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical and medical device company with late stage development programs targeting...
Innocoll to Report Third Quarter 2016 Financial Results and Host Webcast and Conference Call on November 22, 2016
15 nov. 2016 08h30 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, Nov. 15, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...
Innocoll Announces Top-Line Data From Phase 3 Trials With COGENZIA and NDA Submission for XARACOLL
03 nov. 2016 16h31 HE
|
Innocoll Holdings plc
COACT-1 and COACT-2 Phase 3 clinical trials for COGENZIA did not achieve statistical significance in improving clinical cure in diabetic foot infections (DFI)New Drug Application (NDA) for XARACOLL...
Innocoll Holdings plc to Present at the Morgan Stanley Global Healthcare Conference
07 sept. 2016 16h01 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, Sept. 07, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical and medical device company with late stage development programs targeting...
Innocoll to Report Second Quarter 2016 Financial Results and Host Webcast and Conference Call on August 17, 2016
11 août 2016 16h01 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, Aug. 11, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL), a global, specialty pharmaceutical company with late stage development programs targeting areas of...
Innocoll Holdings plc to Present at the JMP Securities Life Sciences Conference
16 juin 2016 09h20 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, June 16, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL) a global, specialty pharmaceutical and medical device company with late stage development programs targeting...